Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab
Author:
Affiliation:
1. Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine, Seoul, South Korea.
2. Department of Ophthalmology, Konyang University College of Medicine, Daejeon, South Korea.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Pharmacology,Ophthalmology
Link
http://www.liebertpub.com/doi/pdf/10.1089/jop.2016.0066
Reference13 articles.
1. The Natural History of Idiopathic Subfoveal Choroidal Neovascularization
2. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age
3. SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
4. Ranibizumab for Neovascular Age-Related Macular Degeneration
5. Intravitreal Bevacizumab for Subfoveal Idiopathic Choroidal Neovascularization
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization;Middle East African Journal of Ophthalmology;2023-04
2. Recurrent Idiopathic Choroidal Neovascularization in an Adolescent;Journal of the Korean Ophthalmological Society;2023-02-15
3. EFFICACY AND SAFETY OF AFLIBERCEPT FOR THE TREATMENT OF IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG PATIENTS;Retina;2022-02
4. Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization;BMC Ophthalmology;2020-03-19
5. Long-Term Efficacy of Intravitreal Conbercept Injection in the Treatment of Idiopathic Choroidal Neovascularization;Journal of Ocular Pharmacology and Therapeutics;2020-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3